Between the Biotech Waves
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
Between the Biotech Waves
Episode 16: A Between the Biotech Waves conversation with Abraham Heifets CEO of Atomwise
•
Nessan Bermingham PhD
•
Season 1
•
Episode 16
Today we talk to Abe Heifets, CEO of Atomwise, a biotech company focusing on the utilization of AI for drug discovery. Atomwise recently (post this recording) announced a $1.2B discovery deal with Sanofi. We discuss AI, its use in drug discovery and development, recent advances and the potential sentient nature of AI. Enjoy.
